These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 34254997)

  • 1. Associations between inflammation, cardiovascular biomarkers and incident frailty: the British Regional Heart Study.
    McKechnie DGJ; Papacosta AO; Lennon LT; Ramsay SE; Whincup PH; Wannamethee SG
    Age Ageing; 2021 Nov; 50(6):1979-1987. PubMed ID: 34254997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Associations between inflammation, coagulation, cardiac strain and injury, and subclinical vascular disease with frailty in older men: a cross-sectional study.
    McKechnie DGJ; Patel M; Papacosta AO; Lennon LT; Ellins EA; Halcox JPJ; Ramsay SE; Whincup PH; Wannamethee SG
    BMC Geriatr; 2022 May; 22(1):405. PubMed ID: 35527242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subclinical cardiovascular disease and frailty risk: the atherosclerosis risk in communities study.
    Jia Y; Li D; Yu J; Liu Y; Li F; Li W; Zhang Q; Gao Y; Zhang W; Zeng Z; Zeng R; Liao X; Zhao Q; Wan Z
    BMC Geriatr; 2022 Apr; 22(1):321. PubMed ID: 35413794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longitudinal increases in blood biomarkers of inflammation or cardiovascular disease and the incidence of venous thromboembolism.
    Folsom AR; Lutsey PL; Heckbert SR; Poudel K; Basu S; Hoogeveen RC; Cushman M; Ballantyne CM
    J Thromb Haemost; 2018 Oct; 16(10):1964-1972. PubMed ID: 30007116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood-Based Cardiac Biomarkers and the Risk of Cognitive Decline, Cerebrovascular Disease, and Clinical Events.
    Gyanwali B; Lai MKP; Lui B; Liew OW; Venketasubramanian N; Richards AM; Chen C; Hilal S
    Stroke; 2021 Jul; 52(7):2275-2283. PubMed ID: 33971742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic Implications of N-Terminal Pro-B-Type Natriuretic Peptide and High-Sensitivity Cardiac Troponin T in EMPEROR-Preserved.
    Januzzi JL; Butler J; Zannad F; Filippatos G; Ferreira JP; Pocock SJ; Sattar N; Verma S; Vedin O; Iwata T; Brueckmann M; Packer M; Anker SD;
    JACC Heart Fail; 2022 Jul; 10(7):512-524. PubMed ID: 35670067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations of 24-Hour Urinary Sodium and Potassium Excretion with Cardiac Biomarkers: The Maastricht Study.
    Martens RJH; Henry RMA; Bekers O; Dagnelie PC; van Dongen MCJM; Eussen SJPM; van Greevenbroek M; Kroon AA; Stehouwer CDA; Wesselius A; Meex SJR; Kooman JP
    J Nutr; 2020 Jun; 150(6):1413-1424. PubMed ID: 32386231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-sensitivity cardiac troponin T in patients with intermittent claudication and its relation with cardiovascular events and all-cause mortality--the CAVASIC Study.
    Pohlhammer J; Kronenberg F; Rantner B; Stadler M; Peric S; Hammerer-Lercher A; Klein-Weigel P; Fraedrich G; Kollerits B
    Atherosclerosis; 2014 Dec; 237(2):711-7. PubMed ID: 25463110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subclinical cardiovascular disease and risk of incident frailty: The British Regional Heart Study.
    McKechnie DGJ; Papacosta AO; Lennon LT; Ellins EA; Halcox JPJ; Ramsay SE; Whincup PH; Wannamethee SG
    Exp Gerontol; 2021 Oct; 154():111522. PubMed ID: 34428478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammation and disease activity are associated with high circulating cardiac markers in rheumatoid arthritis independently of traditional cardiovascular risk factors.
    Avouac J; Meune C; Chenevier-Gobeaux C; Dieudé P; Borderie D; Lefevre G; Kahan A; Allanore Y
    J Rheumatol; 2014 Feb; 41(2):248-55. PubMed ID: 24334650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammatory markers and incident heart failure in older men: the role of NT-proBNP.
    McKechnie DG; Papacosta AO; Lennon LT; Welsh P; Whincup PH; Wannamethee SG
    Biomark Med; 2021 Apr; 15(6):413-425. PubMed ID: 33709785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of interleukin-6 and interleukin-18 with cardiovascular disease in older adults: Atherosclerosis Risk in Communities study.
    Jia X; Buckley L; Sun C; Al Rifai M; Yu B; Nambi V; Virani SS; Selvin E; Matsushita K; Hoogeveen RC; Coresh J; Shah AM; Ballantyne CM
    Eur J Prev Cardiol; 2023 Nov; 30(16):1731-1740. PubMed ID: 37306504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-Sensitivity Cardiac Troponin-T and N-Terminal Prohormone of B-Type Natriuretic Peptide in Relation to Cardiovascular Outcomes in Type 1 Diabetes.
    Costacou T; Saenger AK; Orchard TJ
    Diabetes Care; 2020 Sep; 43(9):2199-2207. PubMed ID: 32616616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natriuretic and Inflammatory Biomarkers as Risk Predictors of Heart Failure in Middle-Aged Men From the General Population: A 21-Year Follow-Up.
    Ergatoudes C; Thunström E; Hansson PO; Morales D; Mandalenakis Z; Rosengren A; Zhong Y; Caidahl K; Fu M
    J Card Fail; 2018 Sep; 24(9):594-600. PubMed ID: 30048772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-terminal Pro B-type Natriuretic Peptide and High-sensitivity Cardiac Troponin as Markers for Heart Failure and Cardiovascular Disease Risks According to Glucose Status (from the Multi-Ethnic Study of Atherosclerosis [MESA]).
    Nguyen K; Fan W; Bertoni A; Budoff MJ; Defilippi C; Lombardo D; Maisel A; Szklo M; Wong ND
    Am J Cardiol; 2020 Apr; 125(8):1194-1201. PubMed ID: 32106929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined use of high-sensitivity cardiac troponin T and N-terminal pro-B type natriuretic peptide improves measurements of performance over established mortality risk factors in chronic heart failure.
    de Antonio M; Lupon J; Galan A; Vila J; Urrutia A; Bayes-Genis A
    Am Heart J; 2012 May; 163(5):821-8. PubMed ID: 22607860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between high-sensitivity cardiac troponin T and N-terminal pro-brain natriuretic peptide in a community based population.
    Xu R; Ye P; Luo L; Sheng L; Wu H; Xiao W; Zheng J; Wang F; Xiao T
    Chin Med J (Engl); 2014; 127(4):638-44. PubMed ID: 24534215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Interplay between Fasting Glucose, Echocardiography, and Biomarkers: Pathophysiological Considerations and Prognostic Implications.
    Pareek M
    Dan Med J; 2017 Sep; 64(9):. PubMed ID: 28874244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-terminal pro-brain natriuretic peptide in relation to inflammation, myocardial necrosis, and the effect of an invasive strategy in unstable coronary artery disease.
    Jernberg T; Lindahl B; Siegbahn A; Andren B; Frostfeldt G; Lagerqvist B; Stridsberg M; Venge P; Wallentin L
    J Am Coll Cardiol; 2003 Dec; 42(11):1909-16. PubMed ID: 14662251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-sensitivity cardiac troponin T and N-terminal pro-B-type natriuretic peptide in acute heart failure: Data from the ACE 2 study.
    Berge K; Lyngbakken MN; Myhre PL; Brynildsen J; Røysland R; Strand H; Christensen G; Høiseth AD; Omland T; Røsjø H
    Clin Biochem; 2021 Feb; 88():30-36. PubMed ID: 33245872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.